Log In
Print
BCIQ
Print
Print this Print this
 

Q203

  Manage Alerts
Collapse Summary General Information
Company Qurient Co. Ltd.
DescriptionInhibitor of Mycobacterium tuberculosis cytochrome bc1, a bacterial enzyme complex needed for respiration.
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationTuberculosis
Indication DetailsTreat extensively drug-resistant tuberculosis (XDR-TB); Treat multi-drug resistant tuberculosis (MDR-TB); Treat tuberculosis
Regulatory Designation

Partner

Infectex Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today